BRENUS PHARMA
Startup
BRENUS PHARMA
Description
Brenus Pharma develops Stimulated Tumor Cells designed for stimulating the host's immune system to induce response following education to recognise tumor associated antigens and tumor specific antigens expressed during treatment with chemotherapy or radiotherapy.
BRENUS PHARMA
Address
France
Contact
Description
Brenus Pharma develops Stimulated Tumor Cells designed for stimulating the host's immune system to induce response following education to recognise tumor associated antigens and tumor specific antigens expressed during treatment with chemotherapy or radiotherapy.
Matchmaking
Connect with BRENUS PHARMA
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways